title: Treatment of Acute Myeloid Leukemia in Adolescent and Young Adult Patients.
abstract: The objectives of this review were to discuss standard and investigational treatment strategies for adolescent and young adult with acute myeloid leukemia, excluding acute promyelocytic leukemia. Acute myeloid leukemia (AML) in adolescent and young adult patients (AYAs) may need a different type of therapy than those currently used in children and older patients. As soon as AML is diagnosed, AYA patient should be offered to participate in well-designed clinical trials. The standard treatment approach for AYAs with AML is remission induction chemotherapy with an anthracycline/cytarabine combination, followed by either consolidation chemotherapy or stem cell transplantation, depending on the ability of the patient to tolerate intensive treatment and cytogenetic features. Presently, continuing progress of novel drugs targeting specific pathways in acute leukemia may bring AML treatment into a new era.
authors.affiliation: Department of Hematology, Ankara University School of Medicine, Ankara 06100, Turkey. guldanecengiz@gmail.com.
authors.forename: Guldane Cengiz
authors.initials: GC
authors.lastname: Seval
authors.affiliation: Department of Hematology, Ankara University School of Medicine, Ankara 06100, Turkey. muhit.ozcan@medicine.ankara.edu.tr.
authors.forename: Muhit
authors.initials: M
authors.lastname: Ozcan
keywords: acute myeloid leukemia; adolescent and young adults; treatment